The combination of oxaliplatin-based treatments ( oxaliplatin plus infusional @-fluorouracil and leucovorin -LSB- FOLFOX -RSB- or oxaliplatin plus capecitabine -LSB- CapeOX -RSB- ) and bevacizumab is a standard chemotherapy regimen for metastatic CRC ( mCRC ) .